You just read:

BioSpecifics Reports Presentation of First Ever Treatment Guidelines for Peyronie's Disease and XIAFLEX Efficacy Data at AUA 2015 Annual Meeting

News provided by

BioSpecifics Technologies Corp.

May 19, 2015, 04:08 ET